Precision medicine firm Caris breaks bio IPO drought

Editor's Pick

Top Story Precision Medicine Firm Caris Breaks Bio IPO Drought, Raising $494M for Cancer Analysis Tools Caris Life Sciences applies AI and machine learning to patient samples to detect cancer and as a companion diagnostic guiding the use of targeted cancer therapies. As a commercial-stage company, Caris's upsized public markets debut is an outlier amid the continuing IPO freeze for clinical-stage biotechs developing new drugs. Sponsored Driving Healthcare Innovation Across Payers, Providers & Life Sciences Presented by Veradigm 88% of providers agree: smoother payer interactions are essential. Veradigm helps bridge the gap between health plans and providers to reduce friction and improve outcomes. Join the network built to support collaboration and real-world success. See how we can help — Click to Learn More.

Featured News

New Cohere Health Solution Aims to Streamline Clinical Reviews for Payers Cohere Health introduced a new tool for payers called Review Assist. It is meant to support health plan clinical staff with prior authorization reviews and other use cases. Why Intermountain Health Is Investing In AI for Clinical Data Abstraction Intermountain Health is deploying Layer Health's AI engine for clinical data abstraction across several of its patient registries. The health system's venture capital arm is also making a strategic investment in the startup. What OpenAI's o3 Price Drop Means for the Future of AI in Healthcare? To be clear, this doesn't mean healthcare organizations should adopt LLMs tomorrow. But what's changed is that the primary obstacle – cost at scale – is no longer the immovable obstacle it once was. For healthcare leaders who have been watching the AI wave from the sidelines, this is the moment to move from curiosity to action. The MFN Executive Order: A Global Reset for U.S. Pharma It's a bold attempt to recalibrate global drug pricing — with U.S. patients at the center. But without clear enforcement, legal grounding, or international cooperation, its future remains very uncertain.

Video   Why Should Employers Be Focused on HIV? At AHIP 2025, Tracy Watts of Mercer discussed why employers should be paying more attention to HIV. "You might be surprised to know that the fastest growing test-positive cohort for HIV is ages 25 to 34 — these are your workers that weren't even alive at the beginning of the AIDS epidemic. Related to that, 80% of the people who transmit HIV don't even know that they have it," she said. In her view, the best thing employers can do to help address this issue is to promote HIV testing.

Sponsored 5 Companies That Offer Mobile IV Therapy With Experienced Nurses in NYC and Beyond Presented by IV Elements Get your IV treatment from wherever you are. These top companies provide mobile IV therapy administered by experienced nurses in NYC and beyond. Learn More

Resources

MedCity Pivot: How Veradigm Aims to Close the Information Gap Megan Zakrewsky, vice president of product at Veradigm talks about how the company is utilizing tech among providers, payers and patients. Watch now!

MedCity News • PO Box 901 • New York, NY unsubscribe